Reflections on the Use of Blood Activation and Stasis Removal in the Treatment of Lung Cancer
Abstract
According to Chinese medicine, lung cancer is a malignant tumour with cough, haemoptysis, chest pain, fever and shortness of breath as its main manifestations. Its causes are: deficiency of positive qi, external invasion of evil toxins, internal accumulation of phlegm, stagnation of qi and blood, obstruction in the lung and loss of suction and descent of the lung. Blood stasis is the main cause of lung cancer, therefore, activating blood circulation and removing blood stasis is an important principle in the treatment of lung cancer. In recent years, the anti-cancer mechanism of traditional Chinese medicine and its extracts has gradually received academic attention, and the herbs that invigorate blood circulation and remove blood stasis have been widely used in clinical practice. This article introduces the mechanism of the action of Chinese medicine to invigorate blood circulation and remove blood stasis in the treatment of lung cancer in recent years, which provides a reference for clinical treatment and new drug development.
References
[2] Girard N.,Popat S.,Rahhali N.,et al. 1117P Amivantamab compared with European, real-world (RW) standard of care (SoC) in adults with advanced non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) exon 20 insertion mutations (exon20ins), after failure of platinum-based therapy[J]. Annals of Oncology,2022:31-35.
[3] Qian YS, Cunsolo Alessandra, Chen Meizhen, et al. Strategies of Mechanical Adaptation of CTCs to Blood Circulation[J]. Biophysical Journal, 2021:120.
[4] Takegami Shigehiko, Konishi Atsuko, Okazaki Shizuno, et al. Effects of mono- and dialkylglucosides on the characterisation and blood circulation of lipid nanoemulsions[J]. Journal of microencapsulation, 2019:36-38.
[5] Sun MQ, Li Y, Hu G, et al. Platelets Lipidomics Study of Blood Stasis Rats Model by Using Liquid Chromatography-tandem Mass Spectrometry[J]. Journal of separation science, 2022: 23-26.
Copyright (c) 2023 Junhui Wang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.